Skip to main content

Perfluorohexyloctane use while Breastfeeding

Medically reviewed by Drugs.com. Last updated on Aug 30, 2024.

Drugs containing Perfluorohexyloctane: Miebo

Perfluorohexyloctane Levels and Effects while Breastfeeding

Summary of Use during Lactation

No information is available on the use of perfluorohexyloctane during breastfeeding. Because perfluorohexyloctane is poorly absorbed, it is not likely to reach the bloodstream of the infant or cause any adverse effects in breastfed infants. No special precautions are required.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Substance Identification

Substance Name

Perfluorohexyloctane

CAS Registry Number

133331-77-8

Drug Class

Breast Feeding

Lactation

Milk, Human

Fluorocarbons

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.